Login / Signup

Low-dose rivaroxaban plus aspirin for elderly patients with symptomatic peripheral artery disease: is it worth the bleeding risk?

Juqian ZhangSrinivasa Rao VallabhaneniGregory Yoke Hong Lip
Published in: European heart journal (2021)
Keyphrases
  • low dose
  • peripheral artery disease
  • atrial fibrillation
  • high dose
  • venous thromboembolism
  • pulmonary embolism
  • cardiovascular events
  • type diabetes
  • cardiovascular disease
  • antiplatelet therapy
  • coronary artery disease